Bausch Health, Formerly Valeant, to Pay $45M in Settlement: SEC

Bausch Health, formerly Valeant Pharmaceuticals, agreed to pay a $45m penalty to settle charges of improper revenue recognition and misleading disclosures in filings and earnings presentations, according to the SEC.

• Former CEO Pearson and former CFO Schiller agreed to pay civil penalties of $250,000 and $100,000 respectively, and to reimburse Valeant $450,000 and $110,000 respectively

To view the source of this information click here

To contact the reporter on this story:
Sonali Pathirana in New York at spathirana@bloomberg.net

To contact the editor responsible for this story:
Stephen Foxwell at sfoxwell@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission. ...